Spiradoline
- Generic Name
- Spiradoline
- Drug Type
- Small Molecule
- Chemical Formula
- C22H30Cl2N2O2
- CAS Number
- 87151-85-7
- Unique Ingredient Identifier
- N18ZH0M4NP
- Background
Spiradoline has been investigated for the basic science of Bipolar Depression.
Proof Of Mechanism Study To Determine Efficacy Of PF-04455242 In Blocking Spiradoline (PF-00345768) Stimulated Prolactin Release
Phase 1
Completed
- Conditions
- Bipolar Depression
- Interventions
- First Posted Date
- 2009-10-02
- Last Posted Date
- 2010-01-07
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 24
- Registration Number
- NCT00988949
- Locations
- 🇸🇬
Pfizer Investigational Site, Singapore, Singapore
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath